7021
of<>363 
the<>362 
and<>240 
in<>207 
to<>148 
with<>134 
a<>107 
for<>88 
were<>85 
was<>85 
patients<>59 
or<>55 
failure<>54 
by<>51 
that<>49 
is<>47 
p<>31 
as<>28 
are<>28 
at<>28 
this<>27 
stage<>26 
t<>26 
from<>25 
after<>24 
results<>24 
dose<>24 
cells<>23 
1<>23 
2<>22 
on<>21 
year<>21 
be<>20 
5<>19 
had<>19 
rate<>18 
tumor<>18 
these<>18 
no<>17 
10<>17 
than<>17 
three<>16 
breast<>16 
pelvic<>16 
c<>15 
using<>14 
all<>14 
their<>14 
gy<>14 
during<>14 
two<>14 
study<>13 
disease<>13 
treated<>13 
which<>13 
doses<>13 
cell<>13 
have<>13 
women<>13 
caesarean<>13 
specific<>13 
we<>13 
up<>13 
other<>13 
rates<>12 
positive<>12 
clinical<>12 
low<>12 
follow<>12 
fetal<>12 
normal<>12 
first<>12 
an<>12 
free<>11 
demonstrated<>11 
years<>11 
response<>11 
tumors<>11 
can<>11 
not<>11 
one<>11 
gastric<>11 
but<>10 
late<>10 
use<>10 
levels<>10 
without<>10 
associated<>10 
radical<>10 
gene<>10 
infants<>10 
bned<>10 
observed<>10 
day<>10 
human<>10 
